AI Stock Finder
Loading...
Skip to main content
Model output · Signal date Oct. 13, 2026

Daily SignalsNeutral

2503 companies scored · Alpha · vs marketSwitch to Total · 30D 90D

Signal date 2026-10-13 Cut-offs from the 2026-10-13 run
Companies scored 2503 IC ≥ 0 · market cap ≥ $100M
Median forecast +0.26% Alpha · 90D
Long–short spread +3.94% Strong Buy minus Strong Sell, mean
Median IC 0.28 Spearman · 90D
Rating changes ▲ 47 ▼ 63 vs the previous run
Cross-section

Distribution of the day's forecasts

90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

Signals · Neutral

74 companies

Sorted by 90D forecast ↓

# Ticker Sector IC Mkt cap Rating 30D 90D Δ
1 TRVITrevi Therapeutics, Inc. Life Sciences 0.32 $1.8B Neutral +0.23% +0.50% ·
2 ELVNEnliven Therapeutics, Inc. Life Sciences 0.40 $2.9B Neutral +0.37% +0.49% ·
3 IRWDIRONWOOD PHARMACEUTICALS INC Life Sciences 0.42 $621M Neutral +0.14% +0.49% ·
4 AMRXAmneal Pharmaceuticals, Inc. Life Sciences 0.02 $6.2B Neutral +0.17% +0.48% ·
5 NUVBNuvation Bio Inc. Life Sciences 0.36 $1.7B Neutral +0.37% +0.46% ·
6 TRLVTrulieve Cannabis Corp. Life Sciences 0.06 $2.0B Neutral +0.23% +0.45% ·
7 VNDAVanda Pharmaceuticals Inc. Life Sciences 0.37 $274M Neutral +0.23% +0.45% ·
8 GNLXGENELUX Corp Life Sciences 0.32 $115M Neutral +0.37% +0.41% ▼ 1
9 ELDNEledon Pharmaceuticals, Inc. Life Sciences 0.00 $190M Neutral +0.38% +0.40% ·
10 IMTXImmatics N.V. Life Sciences 0.26 $967M Neutral +0.37% +0.40% ·
11 VCELVericel Corp Life Sciences 0.27 $2.1B Neutral -0.10% +0.40% ·
12 GILDGILEAD SCIENCES, INC. Life Sciences 0.28 $186.5B Neutral +0.20% +0.38% ·
13 IFRXInflaRx N.V. Life Sciences 0.23 $115M Neutral -0.12% +0.37% ·
14 PTCTPTC THERAPEUTICS, INC. Life Sciences 0.26 $5.3B Neutral +0.20% +0.36% ·
15 ROIVRoivant Sciences Ltd. Life Sciences 0.41 $25.0B Neutral +0.23% +0.35% ·
16 GALTGALECTIN THERAPEUTICS INC Life Sciences 0.10 $390M Neutral +0.21% +0.34% ·
17 ANABANAPTYSBIO, INC Life Sciences 0.56 $1.3B Neutral -0.05% +0.33% ·
18 PRAXPraxis Precision Medicines, Inc. Life Sciences 0.30 $7.0B Neutral +0.23% +0.33% ·
19 SGMTSagimet Biosciences Inc. Life Sciences 0.35 $547M Neutral +0.24% +0.31% ·
20 AMRNAMARIN CORP PLC\UK Life Sciences 0.14 $4.9B Neutral +0.37% +0.29% ·
21 OMEROMEROS CORP Life Sciences 0.46 $1.4B Neutral -0.10% +0.27% ·
22 ONCBeOne Medicines Ltd. Life Sciences 0.00 $517.9B Neutral +0.23% +0.26% ·
23 ALKSAlkermes plc. Life Sciences 0.32 $6.7B Neutral +0.20% +0.25% ·
24 IONSIONIS PHARMACEUTICALS INC Life Sciences 0.52 $7.3B Neutral +0.50% +0.25% ·
25 SIGASIGA TECHNOLOGIES INC Life Sciences 0.47 $227M Neutral +0.23% +0.21% ·
26 ADXNAddex Therapeutics Ltd. Life Sciences 0.02 $449M Neutral +0.23% +0.19% ·
27 ELANElanco Animal Health Inc Life Sciences 0.23 $11.2B Neutral -0.11% +0.19% ·
28 PRGOPERRIGO Co plc Life Sciences 0.56 $2.1B Neutral +0.23% +0.19% ·
29 DFTXDefinium Therapeutics, Inc. Life Sciences 0.29 $4.6B Neutral +0.37% +0.17% ·
30 CYTKCYTOKINETICS INC Life Sciences 0.20 $8.6B Neutral +0.06% +0.16% ·
31 ASMBASSEMBLY BIOSCIENCES, INC. Life Sciences 0.14 $414M Neutral +0.59% +0.15% ·
32 ABUSArbutus Biopharma Corp Life Sciences 0.03 $813M Neutral +0.16% +0.14% ·
33 AGENAGENUS INC Life Sciences 0.08 $313M Neutral +0.28% +0.14% ·
34 MOLNMOLECULAR PARTNERS AG Life Sciences 0.02 $153M Neutral -0.09% +0.13% ·
35 TEVATEVA PHARMACEUTICAL INDUSTRIES LTD Life Sciences 0.03 $48.0B Neutral -0.22% +0.11% ·
36 QDELQuidelOrtho Corp Life Sciences 0.20 $909M Neutral -0.10% +0.06% ·
37 NERVMinerva Neurosciences, Inc. Life Sciences 0.14 $138M Neutral +0.38% +0.04% ·
38 AVXLANAVEX LIFE SCIENCES CORP. Life Sciences 0.03 $137M Neutral +0.23% +0.03% ·
39 AGIOAGIOS PHARMACEUTICALS, INC. Life Sciences 0.02 $1.8B Neutral -0.10% +0.01% ·
40 XTLBXTL BIOPHARMACEUTICALS LTD Life Sciences 0.15 $1.8B Neutral +0.28% +0.01% ·
41 ACHVACHIEVE LIFE SCIENCES, INC. Life Sciences 0.00 $720M Neutral +0.23% -0.01% ·
42 SPRYARS Pharmaceuticals, Inc. Life Sciences 0.26 $416M Neutral +0.89% -0.01% ·
43 AMPHAmphastar Pharmaceuticals, Inc. Life Sciences 0.47 $1.1B Neutral -0.11% -0.02% ·
44 ARVNARVINAS, INC. Life Sciences 0.28 $447M Neutral +0.37% -0.02% ·
45 CLLSCellectis S.A. Life Sciences 0.11 $118M Neutral +1.33% -0.03% ·
46 QUREuniQure N.V. Life Sciences 0.35 $1.4B Neutral +0.23% -0.05% ·
47 NAGENiagen Bioscience, Inc. Life Sciences 0.67 $208M Neutral +0.20% -0.06% ·
48 PCRXPacira BioSciences, Inc. Life Sciences 0.30 $1.4B Neutral +0.21% -0.07% ·
49 SANASana Biotechnology, Inc. Life Sciences 0.32 $784M Neutral +0.50% -0.08% ·
50 VTRSViatris Inc Life Sciences 0.36 $20.1B Neutral -0.08% -0.08% ·
1–50 of 74 Previous Next
Since the previous run

Rating changes

▲ 47▼ 63
Which companies were upgraded or downgraded is part of the paid plans.
Next step

Unlock the full ranking

Every company's rating, its 30- and 90-day forecasts, the forecast and IC-weighted rankings, the daily rating changes and CSV export.

See plans Create a free account
Methodology

Ratings are relative: the forecasts of the latest complete daily run (2026-10-13) are ranked and cut at the 15th, 35th, 65th and 85th percentiles, so Strong Sell is the bottom 15%, Sell the next 20%, Neutral the middle 30%, Buy the next 20% and Strong Buy the top 15%. Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. IC is the company's Spearman information coefficient between its past forecasts and the realised returns at the selected horizon; IC-weighted ranking multiplies each forecast by its IC (negative IC counts as zero). Δ is the rating move since the company's previous signal, in rating steps. Each company shows its latest signal, including one from a run still in progress; every signal is rated against the cut-offs above. Quantitative research output, not investment advice.